Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Molcure, a Japan-based AI-driven drug discovery and developing company backed by University of Tokyo affiliate University of Tokyo Edge Capital (UTEC), has raised $7.2m in series C funding from GMO Venture Partners, Japan Post Capital, Strive and SBI Investment, respective vehicles for internet company GMO, postal service Japan Post, digital media group Gree and financial services…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.